As portfolio manager of Tier 1 Investments, a Motley Fool Real-Money Portfolio, I seek out and invest in elite businesses. These include companies with the strongest competitive advantages, largest growth opportunities, and best management. I call these businesses "Tier 1 enterprises," and the 11 businesses that currently comprise the portfolio have helped Tier 1 earn a 70.97% time-weighted return since inception, compared with the S&P 500's return of 56.61%. But once I build an ownership stake in a business, it's not simply set and forget. I constantly monitor changing industry dynamics in search of threats that can erode the competitive advantages of the companies in my portfolio.
Google (NASDAQ: GOOG ) is currently my largest position in Tier 1, comprising more than 20% of the portfolio. As I see it, here are three of the major threats that Google is facing today.
The Amazon threat
Google makes the great majority of its revenue from connecting businesses with consumers that are searching for products and services to buy. So what happens when these consumers begin to search for those products on Amazon.com (NASDAQ: AMZN ) instead? Thanks to its wide selection of goods, low prices, and excellent customer service, Amazon has become the first and last place that many consumers shop online. Google has taken steps to combat this trend with its product listing ads. These ads appear as a set of product photos with prices and links near the top of Google's search result pages, and also push Amazon's regular search results further down the page -- making them less likely to be clicked. In addition, if these ads increase the convenience of searching for items on Google, it could reverse the tide of people going directly to Amazon.com.
10 Best Oil Stocks To Watch For 2015: Deutsche Bank AG (SBND)
Deutsche Bank AG is a global investment bank. The Company offers a variety of investment, financial and related products and services to private individuals, corporate entities and institutional clients around the world. The Company operates through such divisions as: Private and Business Clients, Asset and Wealth Management, Corporate Banking and Securities, Global Transaction Banking and Non-Core Operations Unit. Deutsche Bank AG is active domestically and in various countries, through the network of numerous branches. In February 2014, the Company and its related bodies corporate ceases to a share holder in the capital of the Company. Advisors' Opinion:- [By Donald van Deventer]
Long-duration Treasury Exchange-Traded Funds: (TLH), , (IEF), (DTYL), (DLBL), (ILTB), (TENZ), (ITE), (TLO), (EDV), (VGIT), (VGLT), (TMF), (TYD), (LBND), (UBT), (UST), (TMV), (TYO), (DSTJ), (DSXJ), (SBND), (PST), (DTYS), (DLBS), (TBF), (TTT), (TYNS), (TYBS), (TBX).
10 Best Low Price Stocks To Invest In Right Now: Green Automotive Co (GACR)
Green Automotive Company, incorporated on November 15, 1996, is a vehicle design, engineering, manufacturing and distribution company. The Company also provides after sales program. It possesses a portfolio of businesses and is active in three main market segments: Cutting edge technology development, engineering and design with a focus on zero and low emission vehicle solutions; Manufacturing and customization of vehicles for markets with the potential to be converted into low emission or electric vehicles, such as shuttle buses, taxis, commercial vehicles, and After sales services for electric or low emission vehicles, including servicing and repair. On December 14, 2012, the Company closed its merger with Matter of Time I Co. As per the merger agreement, Matter of Time I Co. dissolved into and became a part of Green Automotive Company, with Green Automotive Company being the surviving corporation. In January 2014, Green Automotive Co Inc acquired a 21.63% interest in Viridian Motor Corp Inc.
The Company's two divisions servicing the three segments are Liberty Electric Cars Ltd and Newport Coachworks Inc. Liberty Electric Cars Ltd designs and develops EV technologies for use in its own converted vehicles and for sale to original equipment manufacturers (OEM��) for incorporation into its production. In addition, it provides an aftermarket program for electric vehicle users to ensure the longevity of their vehicles. Newport Coachworks Inc. specializes in building shuttle buses, running on a variety of energy sources from petrol and diesel though to compressed natural gas (CNG).
The Company competes with Zytec, AMPD, Siemens, Tiffany, Krystal, Ford, and General Motors, Cummins and Freightliner.
Advisors' Opinion:- [By Bryan Murphy]
On Tuesday of this week, yours truly pointed out that based on 2013's final numbers, Green Automotive Co. (OTCMKTS:GACR) - while not yet a threat to names like Kandi Technologies Group Inc. (NASDAQ:KNDI) or Tesla Motors Inc. (NASDAQ:TSLA) - was coming into its own as an electric vehicle company, and whittling away its uncertainty as an investment. Though a perfectly-clear vision of the future wasn't included in the press release detailing last year's results for GACR, the company did say it would be offering guidance for 2014 later this week. Well, today's the day. And, while KNDI and TSLA still don't have anything to worry about in their immediate future, let's just say Green Automotive still have a lot to look forward to in their foreseeable future.
- [By Bryan Murphy]
While Green Automotive Co. (OTCMKTS:GACR) is certainly no Nissan Motor Co., Ltd. (OTCMKTS:NSANY) or Bayerische Motoren Werke AG (FRA:BMW) (better known as BMW)� in terms of size or notoriety, the two larger car companies certainly seem to be validating the work that GACR is doing. Both Nissan and BMW are betting big on electric vehicles, partly because they want to, and partly because they have to. Either way, Green Automotive is just as capable of tapping into this EV megatrend as its bigger and more established brothers are.
- [By John Udovich]
Electric vehicle industry along with related stocks like Tesla Motors Inc (NASDAQ: TSLA), Kandi Technologies Group Inc (NASDAQ: KNDI), HydroPhi Technologies Group, Inc (OTCMKTS: HPTG) and Green Automotive Co (OTCMKTS: GACR) continue to produce a steady flow of interesting news for investors or would be electric car owners alike:
10 Best Low Price Stocks To Invest In Right Now: Masimo Corporation(MASI)
Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive patient monitoring products worldwide. The company offers Masimo Signal Extraction Technology (SET), which provides the capabilities of measure-through motion and low perfusion pulse oximetry to address the primary limitations of conventional pulse oximetry; and Masimo rainbow SET products that monitor multiple blood measurements, including oxygen content, carboxyhemoglobin, methemoglobin, hemoglobin, pleth variability index, respiration rate, Halo Index, and In Vivo Adjustment. It develops, manufactures, and markets a family of patient monitoring solutions comprising circuit boards, monitors and devices, sensors, and cables; Masimo SafetyNet, a remote monitoring and clinician notification system; and software for Rainbow measurements, as well as other future measurements or features. The company sells its products to hospitals and the emergency medical response organizations through its direct sales force and distributors, as well as to original equipment manufacturer partners in the United States, Europe, the Middle East, Asia, Latin America, Canada, and Australia. Masimo Corporation was founded in 1989 and is headquartered in Irvine, California.
Advisors' Opinion:- [By Seth Jayson]
There's no foolproof way to know the future for Masimo (Nasdaq: MASI ) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your stock craters as a result.
10 Best Low Price Stocks To Invest In Right Now: China Biologic Products Inc.(CBPO)
China Biologic Products, Inc., a biopharmaceutical company, through its subsidiaries, engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the People?s Republic of China. It offers Human Albumin for the treatment of shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and nephropathy; and neonatal hyperbilirubinemia, as well as for the prevention and treatment of low-density-lipoproteinemia. The company also offers Human Hepatitis B Immunoglobulin for the prevention of measles and contagious hepatitis; Human Immunoglobulin and Human Immunoglobulin for Intravenous Injection products for original immunoglobulin deficiency, secondary immunoglobulin deficiency, and auto-immune deficiency diseases; and Thymopolypeptides Injection that is used in the treatment of various original and sec ondary T-cell deficiency syndromes, auto-immune deficiency diseases, and a range of cell immunity deficiency diseases, as well as assists in the treatment for tumors. In addition, it provides Human Rabies Immunoglobulin primarily for passive immunity from bites or claws by rabies or other infected animals; Human Tetanus Immunoglobulin for the prevention and therapy of tetanus; and Placenta Polypeptide that is used for the treatment of cell immunity deficiency diseases, viral infection, and leucopenia caused by various reasons, as well as assists in postoperative heating. The company?s products under development comprise Human Prothrombin Complex Concentrate; Human Coagulation Factor VIII; Human Hepatitis B Immunoglobulin (PH4) for Intravenous Injection; Human Fibrinogen; Varicella Hyperimmune Globulins; and Human Immunoglobulin for Intravenous Injection. The company is based in Beijing, the People's Republic of China.
Advisors' Opinion:- [By Jake L'Ecuyer]
Leading and Lagging Sectors
Healthcare sector moved up 0.39 percent, with Keryx Biopharmaceuticals (NASDAQ: KERX) moving up 15 percent to gain the top spot. Top gainers in the sector included China Biologic Products (NASDAQ: CBPO), with shares up 7.4 percent, and Laboratory Corp. of America Holdings (NYSE: LH), with shares up 5.5 percent. - [By Jake L'Ecuyer]
Leading and Lagging Sectors
Healthcare sector moved up 0.39 percent, with Keryx Biopharmaceuticals (NASDAQ: KERX) moving up 15 percent to gain the top spot. Top gainers in the sector included China Biologic Products (NASDAQ: CBPO), with shares up 7.4 percent, and Laboratory Corp. of America Holdings (NYSE: LH), with shares up 5.5 percent.
10 Best Low Price Stocks To Invest In Right Now: Legg Mason Inc. (LMI)
LMI Aerospace Inc. provides structural assemblies, kits and components, and design engineering services to the aerospace and defense markets in the United States. The company�s Aerostructures segment fabricates, machines, finishes, integrates, assembles, and kits machined and formed close tolerance aluminum, specialty alloy, composite components, and assemblies. Its products include wing slats and flap skins/components, and ailerons; winglet edges and modification kits; fuselage and wing skins; wing panels; helicopter cabin and aft section components; tail cone and edge assemblies; thrust reversers and engine nacelles/cowlings; door components, assemblies, and floor beams; cockpit window frames and landing light lens; and cockpit crew floor and bulkhead structure assemblies. This segment also provides wheel well and electronic rack assemblies; interior components; structural sheet metal, machined, milled, and extruded components; housings and assemblies; auxiliary power u nit components; fans and heat exchangers; ProWall engineered containers; and assemblies and components for rail yard switching equipment. Its Engineering Services segment offers engineering design, analysis, repair, certification, and program management services. This segment provides structural design and analysis services, including wing/wingbox, fixed and moveable leading edges/trailing edges, empennage, and tail cone design; winglet/wing mod design; nacelle, engine cowl, and thrust reverser design; weight improvement engineering; helicopter fuselage, cockpit, cabin frames, skins, longerons, and beams; and aircraft modification engineering services. It also offers systems design and integration, tool design and fabrication, manufacturing engineering, after-market engineering and support, aviation training system, and aviation maintenance engineering; and aviation system software engineering services. LMI Aerospace Inc. was founded in 1948 and is based in St. Charles, Miss ouri.
Advisors' Opinion:- [By Sofia Horta e Costa]
Lonmin Plc (LMI) jumped 2.8 percent to 295 pence, extending its biggest weekly rally in almost four months. Morgan Stanley upgraded the shares to overweight from equal weight, meaning that investors should buy more of the shares. The brokerage described their valuation as attractive.
10 Best Low Price Stocks To Invest In Right Now: Boston Therapeutics Inc (BTHE)
Boston Therapeutics, Inc. is a development-stage company. The Company�� business is the development, manufacture and commercialization of therapeutic drugs and dietary supplements with a focus on glyco-pathology, a specialized field involving understanding the importance of carbohydrates in biochemistry and progression of diseases. The Company is focusing on three products: IPOXYN, an injectable anti-hypoxia drug, which it is developing; PAZ320, which is a non-systemic, chewable drug candidate for reduction of blood glucose in diabetics in development and SUGARDOWN, a complex carbohydrate-based chewable dietary supplement, which it is marketing. The Company�� non-systemic compounds for prediabetes and diabetes, SUGARDOWN and PAZ320, belong to the class of carbohydrate-hydrolyzing enzyme inhibitors.
SUGARDOWN
The Company has developed SUGARDOWN, a non-systemic complex carbohydrate-based dietary supplement to moderate post-meal blood glucose using processes and technology. It has unrestricted access to both sufficient raw materials at commodity pricing and processing facilities to produce sufficient supply of SUGARDOWN to support product distribution across multiple sales channels as a dietary supplement. Its SUGARDOWN dietary supplement consists of a stabilized complex carbohydrate composition. The Company has completed development of SUGARDOWN as a dietary supplement. On January 24, 2012 the Company announced the clinical trial results in healthy volunteers performed at the University of Sydney on SUGARDOWN.
PAZ320
PAZ320 is a non-systemic, non-toxic, chewable drug candidate for prevention of diabetes and its complications. PAZ320 inhibits the enzymes, which release glucose from complex carbohydrate in foods during digestion, reducing the amount of available glucose absorbed through the intestine. PAZ320 is in development as a drug candidate. The Company�� non-systemic compounds for prediabetes and diabetes, SUGARDOWN and PAZ320, belong to the! class of carbohydrate-hydrolyzing enzyme inhibitors.
IPOXYN
The Company has developed a drug candidate product IPOXYN, a glyco-protein based therapeutic agent. Its IPOXYN anti-hypoxia drug consists of a stabilized glycoprotein composition containing oxygen-rechargeable iron, targeting both human and animal tissues and organ systems deprived of oxygen and in need of metabolic support. In addition to potential uses for human patients, it also focuses to file a registration for IPOXYN for veterinary applications under the name OXYFEX. The Company�� pharmaceutical agents are intended for intravenous administration into the circulatory system to target acute and late stage diseases.
Advisors' Opinion:- [By CRWE]
Today, BTHE remains (0.00%) +0.000 at $1.10 thus far (ref. google finance Delayed: 12:25PM EDT October 10, 2013).
Boston Therapeutics has previously closed the final tranche of approximately $1.8 million to bring total gross proceeds of approximately $5.3 million from the private placement of Common Stock and warrants to existing and new accredited investors (the “Offering”).
Proceeds of the offering will be used to fund additional clinical trials for PAZ320, a non-systemic chewable drug designed to reduce the elevation of postprandial glucose or post-meal blood sugar for treatment of patients with Type 2 diabetes, and for general corporate purposes. PAZ320 is the first compound in a new class of therapies for this disease.
10 Best Low Price Stocks To Invest In Right Now: Amicus Therapeutics Inc.(FOLD)
Amicus Therapeutics Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally-administered, small molecule drugs for the treatment of various human genetic diseases. Its drugs are known as pharmacological chaperones, which selectively bind to the target protein, enhance the stability of the protein, help it fold into the three-dimensional shape, and allow proper trafficking of the protein, thereby increasing protein activity, enhance cellular function, and reduce cell stress. The company primarily focuses on lysosomal storage disorders and diseases of neurodegeneration. Its products under development include Amigal, which is in phase III for the treatment of Fabry disease; AT2220, which completed phase I study for the treatment of Pompe disease; and Plicera, that has completed phase I study for the treatment of Gaucher disease. The company has license and collaboration agreement with Glaxo Group Limited to develop and commerc ialize Amigal. The company was founded in 2002 and is based in Cranbury, New Jersey.
Advisors' Opinion:- [By Rick Munarriz]
5. You've got to know when to FOLD 'em
Investing in biotech upstarts can be pretty risky, and Amicus Therapeutics (NASDAQ: FOLD ) investors learned that the hard way this week.
No comments:
Post a Comment